ClinicalTrials.Veeva

Menu

Evaluation of Granulosa Cells Function After IVF Protocols

H

Hospital de Clinicas de Porto Alegre

Status

Unknown

Conditions

Infertility
In Vitro Fertilization Protocols

Treatments

Drug: randomization between the two GnRH analogues (agonist and antagonist)

Study type

Interventional

Funder types

Other

Identifiers

NCT01946022
HCPA (Other Identifier)
13-0120

Details and patient eligibility

About

This study is intended to evaluate ovarian cells after being submitted do different in vitro fertilization protocols. The investigators will analyze hormones secretion and intracellular mechanisms of these cells comparing the GnRH agonist protocol and the GnRH antagonist protocol.

Enrollment

28 estimated patients

Sex

Female

Ages

20 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient age limit: 39 years
  • Follicle Stimulating Hormone (FSH) < 10 micrometer (mU) / Liter
  • Antral follicular count > 12
  • Regular menses (25 to 35 days)
  • More than 3 oocytes after ovarian punction
  • Anti Mullerian between 1 e 3 ng/ml

Exclusion criteria

  • Patients submitted to intracytoplasmatic sperm injection (ICSI)
  • Ovarian mass or cyst
  • Clinical / endocrine pathologies

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

28 participants in 2 patient groups

GnRH Agonist
Active Comparator group
Description:
GnRH long agonist protocol of invitro fertilization
Treatment:
Drug: randomization between the two GnRH analogues (agonist and antagonist)
GnRH Antagonist
Active Comparator group
Description:
GnRH fixed antagonist protocol of in vitro fertilization
Treatment:
Drug: randomization between the two GnRH analogues (agonist and antagonist)

Trial contacts and locations

2

Loading...

Central trial contact

Rita d Chapon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems